Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients
1 other identifier
observational
176
1 country
1
Brief Summary
Aspects of confocal laser micro-endoscopy (CLME) and morphometry in chronic obstructive pulmonary disease (COPD) and lung transplant recipients is described and will be correlated with clinical findings in order to described small airway remodelling in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 17, 2010
CompletedFirst Posted
Study publicly available on registry
September 20, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 30, 2016
December 1, 2016
5.8 years
September 17, 2010
December 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
morphometry
morpohometrical analysis at different time point after lung transplantation
90 - 180 - 360 - 540 - 720 days
Secondary Outcomes (1)
adverse events
90 - 180 - 360- 540- 720 days
Study Arms (3)
COPD
COPD Gold class 1-4
Transplant
Lung transplant recipients
Control
Patients with normal spirometric data
Eligibility Criteria
Patients referred for a bronchoscopic procedure will be asked to undergo CLME. 3 pools will be made: COPD patients according to their pulmonary function test, lung transplant recipients and patients with normal spirometric results. In all groups the difference between active smokers and no-smokers will be made.
You may qualify if:
- referral for bronchoscopic investigation/sampling
- informed consent signed
- recent spirometric data
You may not qualify if:
- sedated and/or ventilated patients
- patients on ICU
- patients under oral anticoagulation
- co-existing lung disease
- acute infectious pulmonary disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
University Hospitals Leuven
Leuven, 3000, Belgium
Related Publications (1)
Yserbyt J, Dooms C, Janssens W, Verleden GM. Endoscopic advanced imaging of the respiratory tract: exploring probe-based confocal laser endomicroscopy in emphysema. Thorax. 2018 Feb;73(2):188-190. doi: 10.1136/thoraxjnl-2016-209746. Epub 2017 Apr 14.
PMID: 28411249DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonas Yserbyt, MD
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Chistophe Dooms, MD, PhD
Universitaire Ziekenhuizen KU Leuven
- STUDY CHAIR
Marc Decramer, MD, PhD
Universitaire Ziekenhuizen KU Leuven
- STUDY CHAIR
Geert Verleden, Md, PhD
Universitaire Ziekenhuizen KU Leuven
- STUDY CHAIR
Wim Janssens, MD, PhD
Universitaire Ziekenhuizen KU Leuven
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
September 17, 2010
First Posted
September 20, 2010
Study Start
September 1, 2010
Primary Completion
July 1, 2016
Study Completion
December 1, 2016
Last Updated
December 30, 2016
Record last verified: 2016-12